Cargando…
Roles of mitochondrial dynamics modulators in cardiac ischaemia/reperfusion injury
The current therapeutic strategy for the management of acute myocardial infarction (AMI) is to return blood flow into the occluded coronary artery of the heart, a process defined as reperfusion. However, reperfusion itself can increase mortality rates in AMI patients because of cardiac tissue damage...
Autores principales: | Maneechote, Chayodom, Palee, Siripong, Chattipakorn, Siriporn C., Chattipakorn, Nipon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661112/ https://www.ncbi.nlm.nih.gov/pubmed/28941171 http://dx.doi.org/10.1111/jcmm.13330 |
Ejemplares similares
-
PCSK9 inhibitor improves cardiac function and reduces infarct size in rats with ischaemia/reperfusion injury: Benefits beyond lipid‐lowering effects
por: Palee, Siripong, et al.
Publicado: (2019) -
Therapeutic potentials of cell death inhibitors in rats with cardiac ischaemia/reperfusion injury
por: Luo, Ying, et al.
Publicado: (2022) -
Pretreatment With PCSK9 Inhibitor Protects the Brain Against Cardiac Ischemia/Reperfusion Injury Through a Reduction of Neuronal Inflammation and Amyloid Beta Aggregation
por: Apaijai, Nattayaporn, et al.
Publicado: (2019) -
Recent Advances in Mitochondrial Fission/Fusion-Targeted Therapy in Doxorubicin-Induced Cardiotoxicity
por: Maneechote, Chayodom, et al.
Publicado: (2023) -
Gasdermin D-mediated pyroptosis in myocardial ischemia and reperfusion injury: Cumulative evidence for future cardioprotective strategies
por: Yanpiset, Panat, et al.
Publicado: (2023)